Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill
Open Access
- 5 June 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (6), e2011192
- https://doi.org/10.1001/jamanetworkopen.2020.11192
Abstract
This cohort study examines the association of thromboelastographic results with hypercoagulability among patients with coronavirus disease 2019 who have been admitted to an intensive care unit.This publication has 8 references indexed in Scilit:
- DOACs and "newer" hemophilia therapies in COVID-19: ReplyJournal of Thrombosis and Haemostasis, 2022
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infectioncclm, 2020
- Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19Journal of Thrombosis and Haemostasis, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Central venous catheter–related thrombosisHematology, 2014